Valuation: Edwards Lifesciences Corporation

Market Cap 49.56B 43.08B 40.1B 36.82B 69.52B 4,731B 70.6B 473B 186B 2,355B 186B 182B 7,898B P/E 2026 *
34x
P/E 2027 * 26.1x
Enterprise Value 46.06B 40.04B 37.27B 34.22B 64.62B 4,397B 65.62B 439B 172B 2,189B 173B 169B 7,340B EV / Sales 2026 *
6.81x
EV / Sales 2027 * 6x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day-0.98%
1 week+4.16%
1 month-8.80%
3 months+2.49%
6 months+4.14%
Current year+0.96%
1 week 82.9
Extreme 82.905
87.08
1 month 81.16
Extreme 81.155
96.29
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap.
7/30/26 Sell

Executive/Senior Manager

-146 0.0000%
7/28/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
7/27/26 Don

Chief Executive Officer

-3,561 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-0.98%+4.16%+8.50%+7.08% 49.56B
-0.43%+1.06%+24.03%+3.71% 212B
-0.61%+1.82%-1.07%-24.39% 137B
+0.10%+4.69%-26.86%+12.57% 125B
+1.59%+5.60%-55.67%-7.68% 69.46B
-0.91%+5.13%-20.61%-25.35% 47.2B
-0.25%-0.14%+21.91%+8.35% 39.08B
-0.79%+0.70%+29.97%+29.32% 37.05B
+0.00%+5.67%+116.67%+8.20% 30.97B
-2.75%+12.28%-2.62%-11.19% 30.72B
Average -0.50%+4.10%+9.42%+0.06% 77.83B
Weighted average by Cap. -0.34%+3.17%+3.45%-1.34%

Financials

2026 *2027 *
Net sales 6.76B 5.88B 5.47B 5.02B 9.48B 645B 9.63B 64.47B 25.3B 321B 25.39B 24.83B 1,077B 7.43B 6.46B 6.01B 5.52B 10.42B 709B 10.58B 70.86B 27.81B 353B 27.9B 27.29B 1,184B
Net income 1.44B 1.25B 1.16B 1.07B 2.01B 137B 2.04B 13.69B 5.37B 68.21B 5.39B 5.27B 229B 1.9B 1.65B 1.53B 1.41B 2.66B 181B 2.7B 18.07B 7.09B 90.06B 7.12B 6.96B 302B
Net Debt -3.5B -3.04B -2.83B -2.6B -4.9B -334B -4.98B -33.35B -13.09B -166B -13.13B -12.84B -557B -5.01B -4.35B -4.05B -3.72B -7.03B -478B -7.14B -47.78B -18.75B -238B -18.81B -18.4B -798B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-07-31 $86.07 -0.98% 3,952,948
26-07-30 $86.92 +1.35% 3,935,938
26-07-29 $85.76 +2.49% 5,594,725
26-07-28 $83.68 +0.77% 5,606,869
26-07-27 $83.04 +0.50% 6,707,520
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
86.07USD
Average target price
100.96USD
Spread / Average Target
+17.30%

Quarterly revenue - Rate of surprise